Lifevantage opened higher at $4.87, compared with its previous close of $4.72. In the last trading session, the stock traded between $4.72 and $5.25. It showed an upward intraday trend.
An investment of $100 made 5 years ago in Lifevantage is now worth
$ 69.30
Resulting in a loss of
$ 30.70 (30.70%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
+$0.30 (+6.29%)
Day High
$5.25
Day Low
$4.72
Day Open
$4.87
Prev Close
$4.72
Volume
1,80,007
1W Return
-14.63%
1M Return
-16.43%
3M Return
-24.86%
6M Return
-2.39%
1Y Return
-23.75%
Market Cap ($ Mn)
64
PE Ratio
15.95
PB Ratio
2.38
PEG Ratio
0.61
ROE
32.20%
ROCE
28.43%
EPS (TTM)
$-0.02
1 Week
-14.63%
1 Month
-16.43%
3 Months
-24.86%
6 Months
-2.39%
9 Months
-1.43%
Lifevantage Q1FY27 Results: Adj EPS $(0.02) misses $0.06 estimate
Lifevantage reported a quarterly loss of $(0.02) per share, missing the $0.06 analyst estimate by 133.33%. Net revenue fell 21.96% YoY to $37.117 million, missing the $40.489 million consensus estimate. Adjusted EBITDA declined 51% to $1.9 million due to margin compression and lower volumes. Operating cash flow improved to $0.5 million from negative $2.3 million in the prior year.
3 days agoLifeVantage to present at WTR Virtual Insights Conference on September 23
LifeVantage Corporation will participate in the WTR Virtual Insights Conference on September 23, 2026. CEO Terrence Moorehead and CFO Carl Aure will represent the company at the event. The webcast presentation is scheduled to begin at approximately 1:30 pm Eastern Time. The event is open access for all investors and interested parties. Registration is available through the company's Investor Relations website.
1mo agoLifeVantage Q4 adjusted EPS $0.11 misses estimate
LifeVantage Q4 adjusted EPS of $0.11 missed the $0.13 estimate. Revenue fell 23.1% YoY to $42.4 million, missing the $45.9M forecast. Subscription revenue comprises over 75% of total sales despite declines. New CEO Terrence Moorhead prioritizes brand building and consumer engagement. Company declared a $0.05 quarterly dividend and maintains debt-free balance sheet.
2mo agoLifeVantage to announce Q4 and FY26 results on August 27
LifeVantage Corporation will announce Q4 and full FY26 results ending June 30, 2026, after market close on August 27. An investor conference call is set for 2:30 pm MT. Replay and webcast options are available.
3mo agoLifeVantage grants 848,765 shares to new CEO Moorehead
LifeVantage Corporation granted 308,642 RSUs and 540,123 PSUs to new CEO Terrence Moorehead under Nasdaq Rule 5635(c)(4). The RSUs vest annually over three years, while PSUs depend on revenue and Adjusted EBITDA margin targets, emphasizing performance-linked compensation.
3mo agoLifeVantage names Terrence Moorehead as CEO and board member
LifeVantage Corporation has officially installed Terrence Moorehead as President, CEO, and Board Member. This move concludes a transition process announced on April 16, 2026, providing clear leadership for the cellular health-focused company.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $167.67 | -0.59% | $3,88,622.68M | 21.72 | |
| $65.78 | -1.04% | $1,61,399.85M | 13.15 | |
| $66.70 | +0.24% | $84,431.39M | 22.93 | |
| $98.00 | -0.09% | $77,902.26M | 35.73 | |
| $108.86 | -1.72% | $66,800.85M | 21.61 | |
| $70.92 | +2.34% | $33,752.18M | 22.34 | |
| $24.27 | +0.12% | $28,731.53M | - | |
| $112.33 | -0.97% | $27,837.96M | 206.78 | |
| $112.02 | +0.23% | $26,440.30M | 32.46 | |
| $176.43 | +1.43% | $25,823.53M | 24.46 | |
| $100.28 | +0.87% | $19,268.20M | 23.00 | |
| $34.21 | -1.13% | $18,291.64M | - |
An investment of $100 made 5 years ago in Lifevantage is now worth
$ 69.30
Resulting in a loss of
$ 30.70 (30.70%)
Note: Past profits do not guarantee future returns.
